Tag: disease activity

Role of interleukin-6 and interferon-α in systemic lupus erythematosus: A case-control study and meta-analysis

This case-control study and accompanying meta-analysis explored the roles of interleukin-6 (IL-6) and interferon-alpha (IFN-α) in systemic lupus erythematosus (SLE). Among 70 SLE patients and 40 matched healthy controls, significantly elevated levels of IL-6 (p < 0.0001) and IFN-α (p = 0.01) were observed in SLE patients, both correlating positively

Read More »

Utility of faecal calprotectin analysis in adult inflammatory bowel disease

This study explores the use of faecal calprotectin (FC) measurement as a non-invasive biomarker for diagnosing and managing inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC). Elevated FC levels correlate with active disease and can help distinguish IBD from other gastrointestinal conditions like irritable bowel syndrome

Read More »

Calprotectin in inflammatory bowel disease

This review article explores the role of calprotectin as a key biomarker in inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis. Elevated levels of calprotectin are closely associated with disease activity, making it an effective non-invasive marker for diagnosing IBD, assessing disease severity, monitoring treatment response, and predicting

Read More »